HIS companies should not be underestimatedIt should be no surprise that healthcare information system vendors are turning their attention to the PACS market. PACS is a high-priced technology that, despite years of being on the cusp of success,
It should be no surprise that healthcare information system vendors are turning their attention to the PACS market. PACS is a high-priced technology that, despite years of being on the cusp of success, remains at a very preliminary level of market implementation, especially in large-scale applications.
Additionally, the technological hurdles that have historically kept IS companies out of the market have largely been removed. Standards like DICOM and HL-7 have eased some of the complex integration requirements, while the exponential increase in PC processing power has enabled development of low-cost workstations and other PACS technology.
Can HIS vendors succeed? Market conditions would seem to favor them. Hospitals continue to consolidate and deal with cost pressures, and information systems that can provide enterprise-wide access to both medical images and patient information could strike a chord in IS departments.
Meanwhile, PACS vendors need to prepare for this eventuality, if they haven't already. By continually working to maintain the highest level of conformance to standards, PACS companies will find themselves still in a strong competitive position even when PACS becomes integrated into an enterprise-wide information system. Thanks to their long experience with the demanding technology, PACS vendors also hold a keen sense of radiology work flow. This is an important lesson that IS vendors must comprehend, because PACS technology that does not pass muster in the radiology department is doomed to failure.
-Erik L. Ridley, Editor
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.